Cancer Gene Therapy

Scientists at University of Alabama, Gene Therapy Center release new data on cancer gene therapy

Published in Pharma Investments, Ventures and Law Weekly, November 19th, 2006

A new study, "Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma," is now available. According to a study from the United States, "Cholangiocarcinoma is a highly malignant neoplasm with no effective treatment. Conditionally replicative adenoviruses (CRAds) represent a promising new modality for the treatment of cancer in general."

"A key contribution in this regard was the introduction of tumor-selective viral replication for amplification of the initial inoculum in the neoplastic cell population. Under ideal conditions following cellular infection, the viruses replicate selectively in the infected tumor cells and kill the cells by...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-11-19)

More Articles from Pharma Investments, Ventures and Law Weekly

Business & Finance
HealthSouth announces stockholder approval of reverse stock split
Dental Research
Danish agency makes statement about tooth whitening products
End-of-Life Issues
Initiative provides advance care directives to ethnically and culturally diverse communities
Finance
Cyberkinetics closes $10 million private placement
Finance
MedicalCV, Inc. announces $2.5 million private financing
Legal Issues
Align Technology and OrthoClear complete definitive agreement
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry